semaglutide vs tirzepatide vs liraglutide and for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States Frontiers | Comparative effectiveness of

But the Australian Health Practitioner Regulation Agency (Ahpra) has expressed concern that health practitioners offering customers access to a predetermined medicine might not be meeting the standards of good medical practice

doi: 10.1016/S0140-6736(15)00803-X 75 NewsomePNBuchholtzKCusiKLinderMOkanoueTRatziuVet al

That approval was based on clinical evidence indicating substantial weight reduction in adults with obesity or overweight and at least one related health condition

Many people assume they must reach the maximum 15 mg dose to see results, but the highest dose isnt always the safest or most effective for maintenance